High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells

Similar Items

• Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
  od: Gameiro, Steven F., i dr.
  Izdano: (2018)
• High MHC-II expression in Epstein–Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation
  od: Ghasemi, Farhad, i dr.
  Izdano: (2020)
• Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers
  od: Prusinkiewicz, Martin A., i dr.
  Izdano: (2020)
• Does HPV Subtype Predict Outcomes in Head and Neck Cancers?
  od: Ziai, Hedyeh, i dr.
  Izdano: (2021)
• Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
  od: Ghasemi, Farhad, i dr.
  Izdano: (2017)